Literature DB >> 2200648

Humoral and cellular immune reactions against retinal antigens in clinical disease.

A Kijlstra1, R Hoekzema, A vd Lelij, G Doekes, A Rothova.   

Abstract

Autoimmune reactions against retinal antigens have been suggested to play an important role in clinical uveitis in man. As yet the evidence for this assertion is very weak. Sympathetic Ophthalmia is a disease entity which comes closest to acceptance as an autoimmune disease although the autoantigen involved has not been identified. Both cellular and humoral autoreactivity against retinal antigens have been found both in uveitis patients as well as in healthy controls. Very high levels of retinal antibodies were found in onchocerciasis patients but no relation was observed with the occurrence of chorioretinitis. Differences were observed when testing patient sera against human or bovine retinal antigens (S-antigen or IRBP) emphasizing the need for using human tissue when investigating autoimmune responses. Circumstantial evidence in favor of an autoimmune etiology of uveitis include the morphology of the inflammatory infiltrate, effect of immuno-suppressive therapy and especially the establishment of experimental animal models. The experimental models of S-antigen or IRBP induced uveitis are primarily T cell mediated and also show pineal gland involvement. As yet no "established" human autoimmune disease has been described with a dominant role for T cells. Furthermore there is no evidence for pineal gland involvement in clinical uveitis. Analysis of the specificity of the T cell infiltrate or deposited immunoglobulins obtained from the diseased tissues may provide conclusive evidence for a possible autoimmune character of certain clinical uveitis entities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200648     DOI: 10.3109/02713689008999425

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

Review 1.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

2.  The antibody response in experimental ocular toxoplasmosis.

Authors:  Justus G Garweg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

3.  Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis.

Authors:  Justus G Garweg; Yvonne de Kozak; Brigitte Goldenberg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-03       Impact factor: 3.117

4.  Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.

Authors:  Lizette M Cortes; Mary J Mattapallil; Phyllis B Silver; Larry A Donoso; Gregory I Liou; Wei Zhu; Chi-Chao Chan; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

5.  Diagnostic approach to ocular toxoplasmosis.

Authors:  Justus G Garweg; Jolanda D F de Groot-Mijnes; Jose G Montoya
Journal:  Ocul Immunol Inflamm       Date:  2011-08       Impact factor: 3.070

Review 6.  Diagnostic techniques for inflammatory eye disease: past, present and future: a review.

Authors:  Stephen C Teoh; Andrew D Dick
Journal:  BMC Ophthalmol       Date:  2013-08-08       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.